ITMI20080038A1 - Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva - Google Patents

Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva

Info

Publication number
ITMI20080038A1
ITMI20080038A1 IT000038A ITMI20080038A ITMI20080038A1 IT MI20080038 A1 ITMI20080038 A1 IT MI20080038A1 IT 000038 A IT000038 A IT 000038A IT MI20080038 A ITMI20080038 A IT MI20080038A IT MI20080038 A1 ITMI20080038 A1 IT MI20080038A1
Authority
IT
Italy
Prior art keywords
mucosites
antitumoral
formulations
induced
treatment
Prior art date
Application number
IT000038A
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Priority to IT000038A priority Critical patent/ITMI20080038A1/it
Priority to CN2009801018866A priority patent/CN101917997A/zh
Priority to PCT/EP2009/000050 priority patent/WO2009087091A2/en
Priority to SI200931657A priority patent/SI2231158T1/sl
Priority to KR1020107015077A priority patent/KR20100100953A/ko
Priority to US12/812,065 priority patent/US8940338B2/en
Priority to CA2711840A priority patent/CA2711840C/en
Priority to DK09700368.5T priority patent/DK2231158T3/en
Priority to AU2009203819A priority patent/AU2009203819B2/en
Priority to RU2010128171/15A priority patent/RU2460535C2/ru
Priority to PT97003685T priority patent/PT2231158T/pt
Priority to EP09700368.5A priority patent/EP2231158B1/en
Priority to HUE09700368A priority patent/HUE035036T2/en
Priority to ES09700368.5T priority patent/ES2629309T3/es
Priority to JP2010541748A priority patent/JP5357896B2/ja
Priority to PL09700368T priority patent/PL2231158T3/pl
Publication of ITMI20080038A1 publication Critical patent/ITMI20080038A1/it
Priority to IL206881A priority patent/IL206881A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60S—SERVICING, CLEANING, REPAIRING, SUPPORTING, LIFTING, OR MANOEUVRING OF VEHICLES, NOT OTHERWISE PROVIDED FOR
    • B60S3/00—Vehicle cleaning apparatus not integral with vehicles
    • B60S3/04—Vehicle cleaning apparatus not integral with vehicles for exteriors of land vehicles
    • B60S3/06—Vehicle cleaning apparatus not integral with vehicles for exteriors of land vehicles with rotary bodies contacting the vehicle
    • B60S3/063—Vehicle cleaning apparatus not integral with vehicles for exteriors of land vehicles with rotary bodies contacting the vehicle the axis of rotation being approximately vertical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mechanical Engineering (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IT000038A 2008-01-11 2008-01-11 Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva ITMI20080038A1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT000038A ITMI20080038A1 (it) 2008-01-11 2008-01-11 Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva
DK09700368.5T DK2231158T3 (en) 2008-01-11 2009-01-08 FORMULATIONS FOR TREATMENT OF MUCOSITIS INDUCED BY ANTITUMOR OR IMMUNSUPPRESSIVE TREATMENT
PT97003685T PT2231158T (pt) 2008-01-11 2009-01-08 Formulações para o tratamento de mucosite induzida por terapêutica antitumoral ou imunossupressora
SI200931657A SI2231158T1 (sl) 2008-01-11 2009-01-08 Formulacije za zdravljenje mukozitisa, induciranega z antitumorsko ali imunosupresivno terapijo
KR1020107015077A KR20100100953A (ko) 2008-01-11 2009-01-08 항종양 요법 또는 면역억제 요법에 의해 유발되는 점막염의 치료를 위한 제제
US12/812,065 US8940338B2 (en) 2008-01-11 2009-01-08 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy
CA2711840A CA2711840C (en) 2008-01-11 2009-01-08 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy
CN2009801018866A CN101917997A (zh) 2008-01-11 2009-01-08 用于治疗由抗肿瘤或免疫抑制治疗诱导的粘膜炎的制剂
AU2009203819A AU2009203819B2 (en) 2008-01-11 2009-01-08 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy
RU2010128171/15A RU2460535C2 (ru) 2008-01-11 2009-01-08 Композиции для лечения мукозита, индуцированного противоопухолевой или иммунодепрессивной терапией
PCT/EP2009/000050 WO2009087091A2 (en) 2008-01-11 2009-01-08 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy
EP09700368.5A EP2231158B1 (en) 2008-01-11 2009-01-08 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy
HUE09700368A HUE035036T2 (en) 2008-01-11 2009-01-08 Preparation for treating mucosal inflammation due to antitumor or immunosuppressive therapy
ES09700368.5T ES2629309T3 (es) 2008-01-11 2009-01-08 Formulaciones de tratamiento de la mucositis inducida por terapia antitumoral o inmunosupresora
JP2010541748A JP5357896B2 (ja) 2008-01-11 2009-01-08 抗腫瘍療法または免疫抑制療法によって誘導される粘膜炎の治療のための製剤
PL09700368T PL2231158T3 (pl) 2008-01-11 2009-01-08 Preparaty do leczenia zapalenia błony śluzowej wywołanego przez terapię przeciwnowotworową lub immunosupresyjną
IL206881A IL206881A (en) 2008-01-11 2010-07-08 Compositions for the treatment of mucosal disease caused by antitumor or immune suppressive therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000038A ITMI20080038A1 (it) 2008-01-11 2008-01-11 Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva

Publications (1)

Publication Number Publication Date
ITMI20080038A1 true ITMI20080038A1 (it) 2009-07-12

Family

ID=40290063

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000038A ITMI20080038A1 (it) 2008-01-11 2008-01-11 Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva

Country Status (17)

Country Link
US (1) US8940338B2 (it)
EP (1) EP2231158B1 (it)
JP (1) JP5357896B2 (it)
KR (1) KR20100100953A (it)
CN (1) CN101917997A (it)
AU (1) AU2009203819B2 (it)
CA (1) CA2711840C (it)
DK (1) DK2231158T3 (it)
ES (1) ES2629309T3 (it)
HU (1) HUE035036T2 (it)
IL (1) IL206881A (it)
IT (1) ITMI20080038A1 (it)
PL (1) PL2231158T3 (it)
PT (1) PT2231158T (it)
RU (1) RU2460535C2 (it)
SI (1) SI2231158T1 (it)
WO (1) WO2009087091A2 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011825A2 (en) 2005-07-19 2007-01-25 Texas Enterosorbent, Inc. Preservative and additive for food and feed
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
KR101479526B1 (ko) 2006-06-27 2015-01-26 더 텍사스 에이 앤드 엠 유니버시티 시스템 칼슘 알루미노실리케이트 클레이를 포함하는, 독소의 장흡수 및 관리를 위한 조성물
CN101904849A (zh) * 2010-08-19 2010-12-08 苏州大学 血根碱制备肿瘤放射治疗增敏药物的应用
WO2013059827A1 (en) * 2011-10-20 2013-04-25 Salient Pharmaceuticals, Inc. Methods and compositions for treating mucositis
AT515336A1 (de) * 2014-02-03 2015-08-15 Roth Hermann Dr Vermeidung oxidativer Prozesse und oxidativem Stress
DK3661490T3 (da) * 2017-07-31 2021-11-22 Mucosa Innovations S L Sammensætning til anvendelse til forebyggelse og/eller behandling af onkologisk behandlings induceret oroga-strointestinal mucositis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254321B (it) * 1992-04-10 1995-09-14 Kemiprogress S R L Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
JP2000109428A (ja) * 1998-10-05 2000-04-18 Taisho Pharmaceut Co Ltd 咽頭粘膜用組成物
ITMI20042414A1 (it) 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US7491414B2 (en) * 2005-10-12 2009-02-17 Gaia Herbs, Inc. Anti-inflammatory substances extracted from Echinacea
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
ITMI20080284A1 (it) * 2008-02-22 2009-08-23 Indena Spa Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono

Also Published As

Publication number Publication date
CA2711840C (en) 2014-02-18
RU2010128171A (ru) 2012-01-20
AU2009203819A1 (en) 2009-07-16
IL206881A0 (en) 2010-12-30
CN101917997A (zh) 2010-12-15
IL206881A (en) 2015-09-24
EP2231158A2 (en) 2010-09-29
US8940338B2 (en) 2015-01-27
EP2231158B1 (en) 2017-04-05
PT2231158T (pt) 2017-07-03
CA2711840A1 (en) 2009-07-16
HUE035036T2 (en) 2018-05-02
WO2009087091A3 (en) 2009-11-26
AU2009203819B2 (en) 2014-07-31
JP2011509270A (ja) 2011-03-24
RU2460535C2 (ru) 2012-09-10
WO2009087091A2 (en) 2009-07-16
ES2629309T3 (es) 2017-08-08
JP5357896B2 (ja) 2013-12-04
US20100284945A1 (en) 2010-11-11
SI2231158T1 (sl) 2017-06-30
DK2231158T3 (en) 2017-06-12
PL2231158T3 (pl) 2017-09-29
KR20100100953A (ko) 2010-09-15
WO2009087091A8 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
SMT201600055B (it) Composizione farmaceutica per il trattamento o la prevenzione del glaucoma
EP2244709A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS
CY2014006I1 (el) Μεθοδοι θεραπευτικης αγωγης χρησιμοποιωντας γλυκοπεγκυλιωμενο g-csf
EP2273989A4 (en) POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
IL208357A0 (en) Spiro-indole derivatives for the treatment of parasitic diseases
GB2479213B (en) Pharmaceutical formulations for the treatment of overactive bladder
ZA201001262B (en) Interval therapy for the treatment of tinnitus
ITMI20080038A1 (it) Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva
EP2184353A4 (en) TREATMENT OF INFLUENZA
IL206435A0 (en) Therapeutic regimens for the treatment of immunoinflammatory disorders
DK2310017T3 (da) Nifurtimox til behandling af sygdomme fremkaldt af trichomonadida
BRPI0908376A2 (pt) Ciclosporina não imunossupressiva para o tratamento de uma distrofia muscular
PL2323625T3 (pl) Nowa kompozycja do leczenia pigmentacji wybroczynowych
EP2203174A4 (en) THERAPEUTIC REGIMES FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
HK1139050A1 (en) Medicament for the treatment of pneumonia
IT1391251B1 (it) Composizione per il trattamento delle patologie articolari
IT1399791B1 (it) Composizioni farmaceutiche per il trattamento della poliposi nasale
IT1397219B1 (it) Composizione farmaceutica o dietetica per il trattamento dell'atopia
IT1406405B1 (it) Molecole peptidiche per il trattamento di patologie mitocondriali
ITMI20080223A1 (it) Apparato per l'applicazione di trattamenti di ipertermia
ITMI20080002A1 (it) Composizioni farmaceutiche per il trattamento della xerostomia, afte e stomatiti
ITRM20080027A1 (it) Uso di aciclovir per il trattamento delle condilomatosi.
GB0809319D0 (en) The treatment of puritus
TH0901004161A (th) การบำบัดรักษาแบบผสมผสาน สำหรับการรักษาการติดเชื้อ hcv